UBS Group »

Tff Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Tff Pharmaceuticals (TFFP) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Tff Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tff Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tff Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $13k 1.8k 7.03

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Tff Pharmaceuticals

DRW Holdings
Westside Investment Management
Vanguard Group
AIGH Capital Management
UBS Group
Jpmorgan Chase & Co
University of Texas Investment Management Company
ORG Partners
Newbridge Financial Services Group
Royal Bank of Canada
Bank of America Corporation
Wells Fargo & Company
Advisor Group Holdings

View all funds holding Tff Pharmaceuticals